Dopaminergic system and neurons: Role in multiple neurological diseases-Reference-Cited by-同舟云学术

Dopaminergic system and neurons: Role in multiple neurological diseases

Published:2024-12 Issue: Volume:260 Page:110133
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Chen Heng,Li Jieshu,Huang Zhixing,Fan Xiaoxiao,Wang Xiaofei,Chen Xing,Guo Haitao,Liu Hao,Li Shuqi,Yu Shaojun,Li Honghong,Huang Xinyu,Ma Xuehua,Deng Xinqi,Wang Chunguo,Liu Yonggang

Funder

NSFC

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference213 articles.

1. New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson's disease symptoms;Al-kuraishy;Neurol. Sci.,2024

2. Parkinson's disease risk and hyperhomocysteinemia: the possible link;Al-kuraishy;Cell. Mol. Neurobiol.,2023

3. Does vitamin D protect or treat Parkinson's disease? A narrative review;Al-kuraishy;N. Schmied. Arch. Pharmacol.,2023

4. The conceivable role of prolactin hormone in Parkinson disease: the same goal but with different ways;Al-kuraishy;Ageing Res. Rev.,2023

5. SARS‐COV‐2 infection and Parkinson's disease: possible links and perspectives;Al‐kuraishy;J. Neurosci. Res.,2023

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced electrochemical and sensing performance of dysprosium-doped CdSiO3: a promising material for supercapacitor and biosensor applications;Materials Science and Engineering: B;2025-11

2. Polymer nanocomposite-based biomolecular sensor for healthcare monitoring;Advances in Colloid and Interface Science;2025-09

3. Neuroadaptation in neurodegenerative diseases: compensatory mechanisms and therapeutic approaches;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2025-06

4. Bridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications;Diabetology;2025-05-08

5. Role of substantia Nigra dopaminergic neurons in respiratory modulation and limitations of levodopa in Parkinson's disease;Experimental Neurology;2025-05